Logo image of CBG.CA

CHIBOUGAMAU INDEPENDENT MINE (CBG.CA) Stock Fundamental Analysis

TSX-V:CBG - CA1671012039 - Common Stock

0.2 CAD
0 (0%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CBG scores 3 out of 10 in our fundamental rating. CBG was compared to 803 industry peers in the Metals & Mining industry. While CBG has a great health rating, there are worries on its profitability. CBG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CBG had negative earnings in the past year.
CBG had a negative operating cash flow in the past year.
CBG.CA Yearly Net Income VS EBIT VS OCF VS FCFCBG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -200K -400K -600K -800K -1M

1.2 Ratios

The Return On Assets of CBG (-5.32%) is better than 70.26% of its industry peers.
CBG has a better Return On Equity (-5.60%) than 71.64% of its industry peers.
Industry RankSector Rank
ROA -5.32%
ROE -5.6%
ROIC N/A
ROA(3y)-57.06%
ROA(5y)N/A
ROE(3y)-78.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBG.CA Yearly ROA, ROE, ROICCBG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CBG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBG.CA Yearly Profit, Operating, Gross MarginsCBG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -1K -2K -3K

More info and screens

9

2. Health

2.1 Basic Checks

The number of shares outstanding for CBG remains at a similar level compared to 1 year ago.
There is no outstanding debt for CBG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBG.CA Yearly Shares OutstandingCBG.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
CBG.CA Yearly Total Debt VS Total AssetsCBG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200K 400K 600K 800K 1M

2.2 Solvency

An Altman-Z score of 225.02 indicates that CBG is not in any danger for bankruptcy at the moment.
CBG has a Altman-Z score of 225.02. This is amongst the best in the industry. CBG outperforms 97.11% of its industry peers.
CBG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 225.02
ROIC/WACCN/A
WACCN/A
CBG.CA Yearly LT Debt VS Equity VS FCFCBG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500K -500K -1M

2.3 Liquidity

CBG has a Current Ratio of 19.46. This indicates that CBG is financially healthy and has no problem in meeting its short term obligations.
CBG has a Current ratio of 19.46. This is amongst the best in the industry. CBG outperforms 91.72% of its industry peers.
CBG has a Quick Ratio of 19.46. This indicates that CBG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CBG (19.46) is better than 91.72% of its industry peers.
Industry RankSector Rank
Current Ratio 19.46
Quick Ratio 19.46
CBG.CA Yearly Current Assets VS Current LiabilitesCBG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

1

3. Growth

3.1 Past

CBG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.14%, which is quite impressive.
CBG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -79.67%.
EPS 1Y (TTM)82.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.54%
Revenue 1Y (TTM)-79.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%141.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBG.CA Yearly Revenue VS EstimatesCBG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CBG.CA Price Earnings VS Forward Price EarningsCBG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBG.CA Per share dataCBG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CBG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHIBOUGAMAU INDEPENDENT MINE

TSX-V:CBG (8/29/2025, 7:00:00 PM)

0.2

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.12%
Ins Owner ChangeN/A
Market Cap12.21M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 98.98
P/FCF N/A
P/OCF N/A
P/B 22.97
P/tB 22.97
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.32%
ROE -5.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-57.06%
ROA(5y)N/A
ROE(3y)-78.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.46
Quick Ratio 19.46
Altman-Z 225.02
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-79.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%141.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-364.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-364.17%
OCF growth 3YN/A
OCF growth 5YN/A